NETRISPHARMA.COM

NETRIS Pharma

Strategic partners and investors. Concept and Link to cancer. Strategic partners and investors. Concept and Link to cancer. WE DEVELOP PIONEER TARGETED THERAPIES FOR THE TREATMENT OF CANCER. Our research is based on the innovative concept of Dependence Receptors. Developing therapies based on cellular mechanisms identified by a world-renowned research group. Our collaborators and partners are driven by a desire to contribute to the development of new ways of fighting cancer. Concept and link to cancer.

http://www.netrispharma.com/

OVERVIEW OF netrispharma.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

16

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR NETRISPHARMA.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

November

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Wednesday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 4.3 out of 5 with 9 reviews

5 star

4

4 star

4

3 star

1

2 star

0

1 star

0

Hey there! Start your review of netrispharma.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

1 seconds

CONTACTS AT NETRISPHARMA.COM

NETRIS PHARMA 28 RUE●●●●●●●●●●●●●●●●●●●●BERARD 69008 LYON FR

33 4●●●●2953

33 4●●●●2887

NO●●@LYON.FNCLCC.FR

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: n/a
UPDATED: 2013 November 20
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

NAME SERVERS

1: ns6.oleane.net
2: ns7.oleane.net

REGISTRAR

ORANGE

WHOIS : whois.oleane.net

REFERRED : http://www.hebergementweb.orange-business.com/noms-de-domaine

CONTENT

PAGES IN
THIS WEBSITE

16

SSL

EXTERNAL LINKS

19

SITE IP

87.98.154.146

LOAD TIME

1.016 sec

SCORE

6.2

PAGE TITLE

NETRIS Pharma | netrispharma.com Reviews

<META> DESCRIPTION

Strategic partners and investors. Concept and Link to cancer. Strategic partners and investors. Concept and Link to cancer. WE DEVELOP PIONEER TARGETED THERAPIES FOR THE TREATMENT OF CANCER. Our research is based on the innovative concept of Dependence Receptors. Developing therapies based on cellular mechanisms identified by a world-renowned research group. Our collaborators and partners are driven by a desire to contribute to the development of new ways of fighting cancer. Concept and link to cancer.

<META> KEYWORDS

1 our company

2 mission

3 management

4 scientific advisory board

5 our science

6 therapeutic strategy

7 research

8 portfolio

9 news

10 careers

CONTENT

Page content here

KEYWORDS ON PAGE

our company,mission,management,scientific advisory board,our science,therapeutic strategy,research,portfolio,news,careers,discover our mission,our biotechnology company,dependence receptors,netris pharma,centre léon bérard,28 rue laennec,france,links

SERVER

Apache

POWERED BY

PHP/7.0.27

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

NETRIS Pharma | netrispharma.com Reviews

https://netrispharma.com

Strategic partners and investors. Concept and Link to cancer. Strategic partners and investors. Concept and Link to cancer. WE DEVELOP PIONEER TARGETED THERAPIES FOR THE TREATMENT OF CANCER. Our research is based on the innovative concept of Dependence Receptors. Developing therapies based on cellular mechanisms identified by a world-renowned research group. Our collaborators and partners are driven by a desire to contribute to the development of new ways of fighting cancer. Concept and link to cancer.

INTERNAL PAGES

netrispharma.com

1

Management | Netris pharma

http://www.netrispharma.com/management

Strategic partners and investors. Concept and Link to cancer. Strategic partners and investors. Concept and Link to cancer. Stéphane Depil, MD, PhD. Agnès Bernet, PhD. Operational and Financial Manager. Jordan Guyon, PharmD. Discover our Scientific Advisory Board. Contact@netrispharma.com 33 (0)4 78 78 29 53.

2

Event | Netris pharma

http://www.netrispharma.com/category/event

Strategic partners and investors. Concept and Link to cancer. Strategic partners and investors. Concept and Link to cancer. 19th-20th May, 2015: Stephane Depil – CEO of NETRIS Pharma – will attend the BioEquity Europe 2015 meeting in Vienna, Austria. NETRIS Pharma will attend the BioEquity Europe 2015 meeting in Vienna, Austria (May 19. 18th-22nd April, 2015: NETRIS Pharma will present recent data about NP137 preclinical development at the AACR Annual Meeting 2015 in Philadelphia, US. NETRIS Pharma will ...

3

Concept and Link to cancer | Netris pharma

http://www.netrispharma.com/concept

Strategic partners and investors. Concept and Link to cancer. Strategic partners and investors. Concept and Link to cancer. The concept of Dependence Receptors and its implication in cancer were pioneered by P.Mehlen laboratory (Mehlen et al. 1998, Nature; Mazelin et al., 2004, Nature; Castets et al., 2012, Nature; Mehlen et al., 2011, Nature Review Cancer). Dependence Receptors play a key role in the control of tumor development and can be considered as tumor suppressors. In addition, the level of Netri...

4

Portfolio | Netris pharma

http://www.netrispharma.com/portfolio

Strategic partners and investors. Concept and Link to cancer. Strategic partners and investors. Concept and Link to cancer. NETRIS Pharma has a first candidate in the late stages of preclinical development, which targets the Netrin-1 ligand. Four other programs are in preclinical research stage. NETRIS Pharma focuses its development activities on monoclonal antibodies. Contact@netrispharma.com 33 (0)4 78 78 29 53.

5

NETRIS Pharma | Netris pharma

http://www.netrispharma.com/author/rabes

Strategic partners and investors. Concept and Link to cancer. Strategic partners and investors. Concept and Link to cancer. All posts by NETRIS Pharma. 6th July 2016: ANR granted the TROY program aiming at targeting Dependence Receptors in oncology and hematology, with NETRIS Pharma as the industrial partner. 31st March, 2016: Agnes Bernet Co-founder and CSO of NETRIS Pharma is nominated as Chevalier de la Légion d’Honneur. NETRIS Pharma announces that Agnès Bernet – co-founder and CSO of NETRIS Ph...

UPGRADE TO PREMIUM TO VIEW 11 MORE

TOTAL PAGES IN THIS WEBSITE

16

LINKS TO THIS WEBSITE

hermione2man.eu

Hermione-2Man partners – Hermione2man.eu

http://www.hermione2man.eu/hermione-2man-partners

45; Potential impact. 45; Hermione-2Man partners. 45; Work package 1. 45; Work package 2. 45; Work package 3. 45; Work package 4. 45; Work Package 5. 45; Work Package 6. Dr Patrick MEHLEN, Centre Anticancéreux Léon Bérard, France. The research leading to these results has received support from the European Union's Seventh Framework Programme.

hermione2man.eu

Hermione-2Man – Hermione2man.eu

http://www.hermione2man.eu/sample-page

45; Potential impact. 45; Hermione-2Man partners. 45; Work package 1. 45; Work package 2. 45; Work package 3. 45; Work package 4. 45; Work Package 5. 45; Work Package 6. Dependence receptor proteins located on the cell surfaces have been linked to tumor progression in some cancers [ 1. However, in the absence of their ligand, these dependence receptors can trigger programmed cell death. The research leading to these results has received support from the European Union's Seventh Framework Programme. Under...

hermione2man.eu

Work package 1 – Manufacturing of anti-Netrin-1 mAb – Hermione2man.eu

http://www.hermione2man.eu/work-package-1

45; Potential impact. 45; Hermione-2Man partners. 45; Work package 1. 45; Work package 2. 45; Work package 3. 45; Work package 4. 45; Work Package 5. 45; Work Package 6. Work package 1 – Manufacturing of anti-Netrin-1 mAb. WP 1 concerns the manufacture of a clinical grade antibody. This requires:. The development and the validation of a manufacturing process, including fermentation and purification steps;. The development of analytical methods. The main objectives are:.

hermione2man.eu

Achievements and publications – Hermione2man.eu

http://www.hermione2man.eu/achievements

45; Potential impact. 45; Hermione-2Man partners. 45; Work package 1. 45; Work package 2. 45; Work package 3. 45; Work package 4. 45; Work Package 5. 45; Work Package 6. 18-22 April 2015, AACR, Philadelphia, Pennsylvania, USA (poster). 16 March 2015, Hermion-2Man project meeting, Vienna, Austria. 5 September 2013, First Hermion-2Man Consortium Assembly, Lyon, France. The research leading to these results has received support from the European Union's Seventh Framework Programme. Under FP7 grant agreement...

remicharreau.com

Netris Pharma • Remi Charreau

http://remicharreau.com/portfolio/netris-pharma

Press enter to begin your search. Jordan G. Operational Manager chez Netris Pharma. Novembre 28, 2014.

emlyonincubateur.wordpress.com

LE CLUB | Incubateur EMLYON

https://emlyonincubateur.wordpress.com/le-club

Cultiver une idée et la voir éclore. Aller au contenu principal. Dispositif d’accompagnement and incubation. Programme Entrepreneurs dans la Ville. ON PARLE DE NOUS…. Xavier et Sylvie JULLIARD, Programme Start-up. Amoeba est une société innovante qui développe, fabrique et commercialise des produits biologiques de rupture et des services pour le traitement des légionelles, des amibes et du biofilm dans les eaux. Fabrice PLASSON, Executive MBA. Systèmes experts pour la personnalisation média multi-écrans.

fr.gtptech.com

Nos références | GTP Technology FR

http://fr.gtptech.com/references

Depuis sa création, GTP a gagné la confiance de plus de 150 clients internationaux. GTP dispose d’une expertise reconnue dans le développement de procédés pour des protéines complexes. Certains d’entre eux nous ont autorisés à citer leur nom :. Institut Cancer et Immunogénétique. Institut de Recherche Servier. Centre de R&D de Tours ,. Jealott's Hill, UK. Science des protéines et bioprocédés. Nous offrons des solutions personnalisées,. Contactez nous pour discuter de votre projet. Tel: 33 (0)5 61 28 70 20.

eclosion.com

Les success stories | Eclosion

http://www.eclosion.com/fr/les-success-stories

L'incubateur des sciences de la vie. Le Conseil de Fondation. Espace entrepreneurs / scientifiques. Le financement des projets. Espace Actualités et évènements. L'incubateur des sciences de la vie. Notre succès est leur succès : les sociétés alumni qui développent des innovations thérapeutiques de rupture. ArisGen élabore des technologies propriétaires de formulation pour l'amélioration des propriétés biopharmaceutiques des peptides et protéines, la délivrance de substances actives dans l'organisme et l'...

eclosion2.com

Portfolio | Eclosion 2

http://www.eclosion2.com/portfolio

A portfolio with outstanding potential. Eclosion has been, from seed, investor in four highly innovative companies developing products or technologies with completely novel mechanisms of action, addressing large unmet medical needs. Novel therapeutic with potential to halt progression in Multiple Sclerosis. First Company to develop targeted therapies against Human Endogenous Retrovirus mediated diseases. BioMérieux, Inserm / Lyon. University of Geneva (CH), Milan (I). Novel therapeutic approach in oncolo...

UPGRADE TO PREMIUM TO VIEW 10 MORE

TOTAL LINKS TO THIS WEBSITE

19

OTHER SITES

netriskprevencion.com

Asesoría Jurídico-Técnica especializada en Prevención - NETRISK Toda la información sobre Prevención de Riesgos Laborales

Asesoría Jurídico-Técnica especializada en Prevención. Asesoría Jurídico-Técnica especializada en Prevención. 12/01/2017 El CSIF pide desfibriladores en todos los edificios del Estado en Córdoba. 12/01/2017 Una profesora de la UPNA analiza la protección del embarazo desde la prevención de la salud. 12/01/2017 Herido tras clavarse un cuchillo por la coz de una res en el matadero. 12/01/2017 Baja laboral del autónomo : lo que debes saber. 12/01/2017 Sectores para emprender en 2017. A través de la página we...

netrisks.info

If you are the owner of this domain name, click here to verify. Review our Privacy Policy.

netrisksolutions.com

Network Security Risk Solutions

Do you feel you network is secure? At least 90% secure. Sunday, 08 March 2009 05:19. This site is under construction. Please contact Nathan Whittacre @ 702-210-6140 or This e-mail address is being protected from spambots. You need JavaScript enabled to view it for more information.

netrisoft.com

Index of /

Apache Server at www.netrisoft.com Port 80.

netrisoft.net

NetriSoft - Home

Call Today: (810) 299-2259. Intelligent Solutions by Design. Is a high-tech software consulting firm with a focus on Microsoft Dynamics CRM. Schedule a Free Consultation. Contact us today for a free demo and needs analysis. When you want CRM in the cloud that is flexible, scalable, and easy to use, don’t get forced. Microsoft Office 365 is cloud productivity designed for you - whether you’re one professional or a small business. 8702 N. Second Street. Brighton, MI 48116. And Terms of Use.

netrispharma.com

NETRIS Pharma

Strategic partners and investors. Concept and Link to cancer. Strategic partners and investors. Concept and Link to cancer. WE DEVELOP PIONEER TARGETED THERAPIES FOR THE TREATMENT OF CANCER. Our research is based on the innovative concept of Dependence Receptors. Developing therapies based on cellular mechanisms identified by a world-renowned research group. Our collaborators and partners are driven by a desire to contribute to the development of new ways of fighting cancer. Concept and link to cancer.

netristbeta.com

Default Parallels Plesk Page

Web Server's Default Page. This page is generated by Parallels Plesk. The leading hosting automation software. You see this page because there is no Web site at this address. You can do the following:. Create domains and set up Web hosting using Parallels Plesk. Parallels is a worldwide leader in virtualization and automation software that optimizes computing for consumers, businesses, and Cloud services providers across all major hardware, operating systems, and virtualization platforms.

netristwebdesign.com

Netrist Web Design in Charleston SC - Web Design and Web Development Services » Netrist Solutions

Top-Tier Web Design and Development. Need a New Web Design? We design sites that attract customers. Netrist will create a compelling. Website unique to your business. Your site will reach visitors through search engines. AccuTrak Inventory Specialists needed a site that would give each of their franchisees a home on the web. Netrist created a "Hub" system that lets each franchisee add and update content specific to their office and geographic area. St Joseph St. Thomas Parish. St Joseph St. Thomas is...

netristwebhosting.com

Default Web Site Page

If you are the owner of this website, please contact your hosting provider: webmaster@netristwebhosting.com. It is possible you have reached this page because:. The IP address has changed. The IP address for this domain may have changed recently. Check your DNS settings to verify that the domain is set up correctly. It may take 8-24 hours for DNS changes to propagate. It may be possible to restore access to this site by following these instructions. For clearing your dns cache.

netrite.com

Netrite.com is for sale! Click here to inquire.

netrite.net

NetRite - Web App Development

Netrite Web App Development. Professional Web App Development. 2018 Netrite. Company No: 07750886 Registered in England. Address: NetRite Ltd, 8 Christow Road, Exeter, EX2 8QP. Netrite Web App Development.